Neuroprotective Biologics
We have discovered Neuroprotective Biologics that are secreted by certain of our neurosensory retina progenitor cell populations. We anticipate that the neuroprotective agent(s) that we may ultimately develop as drug candidates may be useful not only in retinal diseases and dystrophies, but may have broader applications in central nervous system and peripheral nervous system diseases and disorders, including diseases causing cognitive function impairment, movement disorders such as Parkinson’s Disease, and ischemic events such as caused by stroke.
https://www.ocata.co...dicine-programs
Robert Lanza
Dr. Robert Lanza has over 30 years of research and industrial experience in the area of stem cells and regenerative medicine. He is currently an Adjunct Professor at the Institute for Regenerative Medicine at Wake Forest University School of Medicine. He has several hundred publications and inventions, and over 30 scientific books: among them, “Essentials of Stem Cell Biology” and “Principles of Tissue Engineering” which are recognized as the definitive references in the field. Others include “Principles of Regenerative Medicine” and “One World: The Health & Survival of the Human Species in the 21st Century” (as editor, with forewords by C. Everett Koop and former President Jimmy Carter).
https://www.ocata.co...ship/management
This is in the drug discovery phase. Detailed information not yet available from what I can gather. Will be following. If you find further information, please share. Thanks
